Page 16 - <>期刊 v2

16
Back
ID D N U | iddnu@suntrap.com | www.suntrap.com

nism of patients infected with SARS-CoV-2, the Sun- the virus load in the mouth and nose, and reduce the
trap’s research team optimized and developed dif- probability of aggravation; (2) it inhibits the combi-
ferent clinical protocols. The basic formulation was nation of SARS-CoV-2 and sialic acid, and then helps
completed in November 2020. the human immune system to recognize the viruses;
(3) LeSoleil-T is positively charged and can effectively
LeSoleil the broad-spectrum anti-COVID-19 protec-
adsorb negatively charged SARS-CoV-2 virus, so as to
tive and therapeutic spray include three types: Le-
inhibit the transfer of viruses in host cells; (4) it can
Soleil-01, oral spray; LeSoleil-02, nasal spray; and
inhibit the production of pro-inflammatory factors to
LeSoleil-02 , preventive and therapeutic ultrasonic at-
+
inhibit inflammation, and effectively treat upper re-
omizing inhaler. The broad-spectrum anti-COVID-19
spiratory tract inflammation and other related symp-
protective and therapeutic spray is suitable for
toms caused by COVID-19; (5) it has a dynamic con-
COVID-19 protection and patients with asymptom-
sistency similar to that of the mucus of the oral cavity
atic or mild infection. LeSoleil-03 is a therapeutic
and nasal cavity, which can make the broad-spec-
“anti-COVID-19 aerosol inhaler”, which is suitable
trum anti-coronavirus protective and therapeutic
for patients with moderate and severe SARS-CoV-2
spray evenly adhere to the mucous membrane after
infection. In addition, LeSoleil-03 can also be used in
reaching the oral cavity and nasal cavity, forming a
patients with pulmonary fibrosis sequelae caused by
“biological protective film” that lasts for a long time.
SARS-CoV-2 infection. All of these three preparations
For some asymptomatic or mildly infected people, a
are suitable for children, adults and the elderly.
small amount of the virus will be excreted when they
The LeSoleil broad-spectrum anti-coronavirus pro- cough, sneeze or exhale. After using a broad-spec-
tective and therapeutic spray is portable and easy trum anti-coronavirus protective and therapeutic
to use. It effectively prevents healthy people from spray, the active ingredient LeSoleil-T can inhibit the
infection and blocks the spread of SARS-CoV-2 from excreted virus and block the route of virus transmis-
asymptomatic and mild COVID-19 patients. LeSoleil sion to achieve a more extensive protective effect.
broad-spectrum anti-coronavirus protective and
For patients with moderate and severe SARS-CoV-2
therapeutic spray can cope with the prevention and
infections, it is recommended to use LeSoleil-03 twice
treatment of SARS-CoV-2 and variant strains (e.g.,
a day to treat the infection and inflammation in the
Delta and Omicron.). In addition, the preclinical study
respiratory tract and lungs. It is convenient for pa-
conducted by the Suntrap team revealed that LeSoleil
tients to use, including dissolving LeSoleil-03 in ster-
can also be used for upper respiratory tract infections
ile water and then inhaling through the respiratory
caused by influenza viruses and mutant strains (e.g.,
tract directly to the lungs via a ventilator and medical
H1N1, H5N1, H7N1, H7N2, H7N3, H7N7, H7N9, H9N2
atomizing device. The characteristics and efficacies
and H10N8). The new corresponding symptoms still
of LeSoleil-03 are as follows: (1) it has a small parti-
need to be verified by clinical research.
cle size and no foreign body sensation, and it is easy
The characteristics of LeSoleil broad-spectrum an- to inhale with medical machinery or a small medi-
ti-coronavirus protective and therapeutic spray are cal-grade ultrasonic atomization device and reach
as follows: (1) it can inhibit virus replication, control the lungs through the bronchus to avoid the first-pass
effect; (2) the local drug concentration is high, and it